Enzyme immunoassays for measuring complement-dependent prevention of immune precipitation (PIP) and solubilization of preformed antigen-antibody complexes (SOL)

被引:8
作者
Arason, GJ [1 ]
D'Ambrogio, MS [1 ]
Víkingsdóttir, T [1 ]
Sigfússon, A [1 ]
Valdimarsson, H [1 ]
机构
[1] Natl Univ Hosp Reykjavik, Dept Immunol, IS-101 Reykjavik, Iceland
关键词
immunoenzyme techniques; antigen-antibody complex; complement;
D O I
10.1016/S0022-1759(98)00199-9
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
We have developed simple and sensitive enzyme-based methods for evaluating the ability of serum complement to prevent immune complex precipitation (PIP) or to solubilize preformed immune complexes (SOL). Alkaline phosphatase, serving both as antigen and label, is added to goat IgG anti-alkaline phosphatase antibodies, with serum present throughout the assay (PIP), or added after immune complex formation (SOL). After incubation at 37 degrees C for 1 h followed by centrifugation, the enzyme activity of the supernatant, reflecting the amount of immune complexes in solution, is measured by colorimetry. Results are expressed with reference to a standard serum pool assigned 100 arbitrary units (AU). Intra- and inter-assay Variabilities are within 10%. The normal ranges were 67-133 AU for PIP and 72-129 AU for SOL. These methods have been standardized for clinical use in relation to impaired complement function and immune complex disease, and adapted for measuring complement mediated binding of immune complexes to erythrocytes. They are sensitive, easy to perform and do not require expensive facilities. By measuring the interaction of complement with immune complexes, these methods may highlight aspects of the classical and the alternative pathway that are different from those detected using haemolysis as an endpoint. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:37 / 46
页数:10
相关论文
共 26 条
[1]  
AHMED AEE, 1990, IMMUNOLOGY, V70, P139
[2]  
ARASON GJ, 1998, UNPUB ARTHRITIS RHEU
[3]   A STANDARDIZED METHOD FOR QUANTITATING THE COMPLEMENT-MEDIATED IMMUNE-COMPLEX SOLUBILIZING CAPACITY OF HUMAN-SERUM [J].
BAATRUP, G ;
PETERSEN, I ;
SVEHAG, SE ;
BRANDSLUND, I .
JOURNAL OF IMMUNOLOGICAL METHODS, 1983, 59 (03) :369-380
[4]   STUDIES ON MECHANISM OF SOLUBILIZATION OF IMMUNE PRECIPITATES BY SERUM [J].
CZOP, J ;
NUSSENZWEIG, V .
JOURNAL OF EXPERIMENTAL MEDICINE, 1976, 143 (03) :615-630
[5]   THE EFFECTS OF IMMUNOGLOBULIN ISOTYPE AND ANTIBODY-AFFINITY ON COMPLEMENT-MEDIATED INHIBITION OF IMMUNE PRECIPITATION AND SOLUBILIZATION [J].
JOHNSON, A ;
HARKIN, S ;
STEWARD, MW ;
WHALEY, K .
MOLECULAR IMMUNOLOGY, 1987, 24 (11) :1211-1217
[6]  
LACHMANN PJ, 1987, CIBA F SYMP, V129, P149
[7]  
LACHMANN PJ, 1990, CHEM IMMUNOL, V49, P245
[8]   NEW COMPLEMENT FUNCTION - SOLUBILIZATION OF ANTIGEN-ANTIBODY AGGREGATES [J].
MILLER, GW ;
NUSSENZWEIG, V .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1975, 72 (02) :418-422
[9]  
MITCHELL WS, 1984, IMMUNOLOGY, V52, P445
[10]  
NAAMA JK, 1985, CLIN EXP IMMUNOL, V60, P169